Zurueck zur Suche

Reporte zur Charge U013969

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

11Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 3 FL 3 WV 1 MD 1 PA 1 HI 1 MI 1

VAERS 1889479

MERCK & CO. INC. · HEP A (VAQTA) · Charge U013969

mild
Staat
WV
Alter
1,0
Geschlecht
F
Eingang
22.11.2021
Impfdatum
13.10.2021
Beginn
18.10.2021
Tage bis Beginn
5,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash erythematous

Symptomtext

Approximately 5 days after the vaccine was administered, the patient developed a red, circular area on the left thigh. At the time of her well child check up on 10/13/21, the varicella vaccine was given in the left leg and the MMR and Hep A vaccines were given in right leg. It may be an inflammatory reaction secondary to injection technique (suspicion that this vaccine may have been given IM instead of subcutaneous and that this may be the cause of this reaction). She presented for evaluation of this concern on 10/26/21. with her mother. At that time, I had a low concern for cellulitis or abscess since she was afebrile and over the past several days, the area of redness/concern had not increased in size. We marked area on the left leg with a surgical pen to watch for spreading of the erythema. Advised that the family can use warm compresses to the area. Also advised that they can use Zyrtec daily for itching.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash erythematous
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Choking/gagging episodes, constipation
Vorgeschichte
None
Andere Medikamente
MIRALAX as needed
Allergien
Egg allergy as per allergy testing results. Milk protein induced proctocolitis
Vorherige Impfungen
-

VAERS 1788125

MERCK & CO. INC. · HEP A (VAQTA) · Charge U013969

mild
Staat
MD
Alter
2,0
Geschlecht
F
Eingang
15.10.2021
Impfdatum
28.09.2021
Beginn
28.09.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site infection

Symptomtext

Infection at site of immunization, 15 days after injection. Prescribed antibiotics

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site infection
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
none known
Allergien
none
Vorherige Impfungen
-

VAERS 2585251

MERCK & CO. INC. · HEP A (VAQTA) · Charge U013969

gering
Staat
PA
Alter
-
Geschlecht
U
Eingang
22.02.2023
Impfdatum
15.02.2023
Beginn
15.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AEs; Caller reported expired dose of VAQTA was administered. No other information provided. No additional AEs or PQC reported.; This spontaneous report was received from an unspecified reporter and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 15-FEB-2023, the patient was vaccinated with expired hepatitis a vaccine, inactivated (VAQTA) 0.5 milliliter, administered intramuscular, lot #U013969, expiration date 06-FEB-2023 (anatomical location was not reported) for prophylaxis (expired product administered). No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2336275

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (OTHER) · Charge U013969

gering
Staat
HI
Alter
0,2
Geschlecht
M
Eingang
27.06.2022
Impfdatum
24.05.2022
Beginn
24.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

Pediatric Hep A Vaccine given to patient mistakenly. Pt's father contacted by MD and informed. Father stated patient doing ok. No issues

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NKA
Vorherige Impfungen
-

VAERS 1975299

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge U013969

gering
Staat
MI
Alter
1,3
Geschlecht
F
Eingang
23.12.2021
Impfdatum
-
Beginn
20.12.2021
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administration error

Symptomtext

patient received DTAP -IPV and Needed just DTAP

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administration error
Hospital-Tage
-
Labordaten
N/a
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 1871949

MERCK & CO. INC. · HEP A (VAQTA) · Charge U013969

gering
Staat
FL
Alter
-
Geschlecht
U
Eingang
16.11.2021
Impfdatum
20.10.2021
Beginn
20.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional adverse events; 10/20/2021 one dose of an improperly stored V AQT A vaccine was administered; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medication were not reported. On 20-OCT-2021, the patient was vaccinated with improperly stored dose of hepatitis a vaccine, inactivated(VAQTA) lot # U013969 was confirmed to be valid, expiration date 06-FEB-2023 (exact dose, route of administration, anatomical location were not reported) for prophylaxis. The temperature excursion was 51 degrees Fahrenheit for 4 hours and 15 minutes. There were no previous excursions reported. No adverse effects were reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2110USA006206: US-009507513-2110USA005970:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1848059

MERCK & CO. INC. · HEP A (VAQTA) · Charge U013969

gering
Staat
FL
Alter
-
Geschlecht
U
Eingang
06.11.2021
Impfdatum
20.10.2021
Beginn
20.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No further AE reported; Improperly stored vaccine were administered; This spontaneous report as received from a nurse referring to a patient of unknown age and gender. The patient's medical history, concomitant medications, drug allergies, or reactions were not reported. On 20-OCT-2021, the patient was vaccinated with improperly stored doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) lot # T022311, has been verified to be valid for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live expiry date 30-JUN-2022 and hepatitis a vaccine, inactivated(VAQTA) lot # U013949, has been verified to be valid for hepatitis a vaccine, inactivated expiry date 06-FEB-2023, 1 dosage form of both of them for prophylaxis (administration route was not provided) (product storage error). The vaccines were exposed to a temperature of 40 Fahrenheit degrees for 6 hours, no previous temperature excursions or adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1717775

MERCK & CO. INC. · HEP A (VAQTA) · Charge U013969

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
21.09.2021
Impfdatum
16.08.2021
Beginn
16.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional adverse effect reported; underwent a temperature excursion that took place on 8/13/2021 were administered; This spontaneous report has been received from a reporter specified as other, referring to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided. On 16-AUG-2021, the patient was vaccinated with hepatitis A vaccine, inactivated (VAQTA) (lot number U013969 has been verified to be valid, expiration date reported and established as 06-FEB-2023) and varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot number T037642 has been verified to be valid, expiration date reported and established as 06-NOV-2022) as prophylaxis (doses, routes of administration, anatomical sites of vaccination and vaccine schemes were not reported). The vaccine hepatitis A vaccine inactivated (VAQTA) was exposed to a temperature excursion of below 36 degrees Fahrenheit (32.9?F) during a time frame of 90 hours. The vaccine varicella virus vaccine live (Oka/Merck) (VARIVAX) was exposed to a temperature excursion of 14 degrees Fahrenheit to 46 degrees Fahrenheit (32.9?F) for 90 hours (product storage error). There was no previous temperature excursion. No additional adverse event (no adverse event) was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2109USA003185:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1717774

MERCK & CO. INC. · HEP A (VAQTA) · Charge U013969

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
21.09.2021
Impfdatum
13.08.2021
Beginn
13.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional adverse effect reported; underwent a temperature excursion that took place on 8/13/2021 were administered; This spontaneous report has been received from a reporter specified as other, referring to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided. On 13-AUG-2021, the patient was vaccinated with hepatitis A vaccine, inactivated (VAQTA) (lot number U013969 has been verified to be valid, expiration date reported and established as 06-FEB-2023) and varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot number T037642 has been verified to be valid, expiration date reported and established as 06-NOV-2022) as prophylaxis (doses, routes of administration, anatomical sites of vaccination and vaccine schemes were not reported). The vaccine hepatitis A vaccine inactivated (VAQTA) was exposed to a temperature excursion of below 36 degrees Fahrenheit (32.9?F) during a time frame of 90 hours. The vaccine varicella virus vaccine live (Oka/Merck) (VARIVAX) was exposed to a temperature excursion of 14 degrees Fahrenheit to 46 degrees Fahrenheit (32.9?F) for 90 hours (product storage error). There was no previous temperature excursion. No additional adverse event (no adverse event) was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2109USA003185:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1717772

MERCK & CO. INC. · HEP A (VAQTA) · Charge U013969

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
21.09.2021
Impfdatum
13.08.2021
Beginn
13.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional adverse effect reported; underwent a temperature excursion that took place on 8/13/2021 were administered; This spontaneous report has been received from a reporter specified as other, referring to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided. On 13-AUG-2021, the patient was vaccinated with hepatitis A vaccine, inactivated (VAQTA) (dose, route of administration, anatomical site of vaccination and vaccine scheme were not provided; lot number U013969 has been verified to be valid, expiration date reported and established as 06-FEB-2023) as prophylaxis. The vaccine was exposed to a temperature excursion of below 36 degrees Fahrenheit (32.9?F) during a time frame of 90 hours (product storage error). There was no previous temperature excursion. No additional adverse event (no adverse event) was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2109USA003304: US-009507513-2109USA003305: US-009507513-2109USA003303: US-009507513-2109USA003302: US-009507513-2109USA003301:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1638809

MERCK & CO. INC. · HEP A (VAQTA) · Charge U013969

gering
Staat
FL
Alter
20,0
Geschlecht
M
Eingang
27.08.2021
Impfdatum
16.08.2021
Beginn
16.08.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Underdose

Symptomtext

No additional adverse events reported; administration of a pediatric dose of VAQTA to a 20 year old male; administration of a pediatric dose of VAQTA to a 20 year old male; This spontaneous report as received from a nurse and refers to a 20-year-old male patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 16-AUG-2021, the patient was vaccinated with a pediatric dose of hepatitis a vaccine, inactivated (VAQTA) lot # U013969 was confirmed to be valid, expiration date 06-FEB-2023, 0.5 milliliter (route of administration, anatomical location were not reported) for prophylaxis. No adverse effects were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-